Literature DB >> 31633563

Carbapenemase-producing Enterobacteriaceae - once positive always positive?

Jasper P Vink1, Jon A Otter, Jonathan D Edgeworth.   

Abstract

PURPOSE OF REVIEW: This review provides an overview of gastrointestinal tract colonization with carbapenemase-producing Enterobacteriaceae (CPE), including risk factors for colonization, determinants for duration of colonization, and whether patients can decolonize, either spontaneously or via targeted interventions. RECENT
FINDINGS: CPE colonization is disseminating globally with increasing numbers of carbapenemases being identified in increasing patient cohorts. Numerous risk factors including repeated healthcare contact, patient co-morbidities and international travel have all been linked to increased rates of colonization. Duration of colonization has been investigated in various healthcare settings and ranges many months or even years. Although new methods for expediting decolonization are being investigated, including faecal microbiota transplantation, high quality evidence of impact is lacking.
SUMMARY: Current evidence indicates that CPE colonization usually persists throughout the duration of most hospital admissions, although the majority of patients will subsequently spontaneously decolonize. Difficulties remain in determining the point at which patients can be considered decolonized because of the lack acceptable criteria for defining eradication. This has significance implications for infection prevention and control measures during the initial and subsequent hospital admissions. Strategies to reduce the healthcare burden of CPE colonization continue to rely predominantly on preventing acquisition, whereas decolonization efforts remain a focus of research.

Entities:  

Mesh:

Year:  2020        PMID: 31633563     DOI: 10.1097/MOG.0000000000000596

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  3 in total

1.  Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial.

Authors:  Blair Merrick; Emily Robinson; Catey Bunce; Liz Allen; Karen Bisnauthsing; Chi Chi Izundu; Jordana Bell; Gregory Amos; Manu Shankar-Hari; Anna Goodman; Debbie L Shawcross; Simon D Goldenberg
Journal:  BMJ Open       Date:  2020-05-25       Impact factor: 2.692

2.  Comprehensive, multisystem, mechanical decolonization of Vancomycin-Resistant Enterococcus and Carbapenem-Resistant Enterobacteriacease without the use of antibiotics.

Authors:  Eunseok Choi; Sook Joung Lee; Sangjee Lee; Jinseok Yi; Yeon Soo Lee; So-Youn Chang; Ho Young Jeong; Yunwoo Joo
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

3.  Absence of transmission of NDM and OXA-48 carbapenemase genes in a chronic care unit of a long-term care facility.

Authors:  Carl Boodman; Natalie Gibson; Davenna Conrod; Christine Y Turenne; David C Alexander; Tatyana Taubes; Ana Lucha; David A Boyd; Laura F Mataseje; Michael Mulvey; James A Karlowsky; Molly Blake; John M Embil
Journal:  J Infect Prev       Date:  2021-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.